UPDATE 1-Teva scraps cluster headache program By: Reuters: Company News April 23, 2019 at 09:35 AM EDT Teva Pharmaceutical Industries Ltd said on Tuesday it would stop developing its migraine drug, Ajovy, for treating cluster headaches. Read More >> Related Stocks: Amgen Eli Lilly Teva Pharmaceutical Industries ADR